These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 30325973)

  • 21. Plasma neutrophil gelatinase-associated lipocalin (NGAL) is an indicator of interstitial damage and a predictor of kidney function worsening of chronic kidney disease in the early stage: a pilot study.
    Moriya H; Mochida Y; Ishioka K; Oka M; Maesato K; Hidaka S; Ohtake T; Kobayashi S
    Clin Exp Nephrol; 2017 Dec; 21(6):1053-1059. PubMed ID: 28397074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nondipping pattern on 24-h ambulatory blood pressure monitoring is associated with left ventricular hypertrophy in chronic kidney disease.
    Jaques DA; Müller H; Martinez C; De Seigneux S; Martin PY; Ponte B; Saudan P
    Blood Press Monit; 2018 Oct; 23(5):244-252. PubMed ID: 29958233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysis.
    Han BG; Lee JY; Kim MR; Shin H; Kim JS; Yang JW; Kim JY
    PLoS One; 2020; 15(7):e0235640. PubMed ID: 32730268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin.
    Lábr K; Špinar J; Pařenica J; Špinarová L; Málek F; Špinarová M; Ludka O; Jarkovský J; Benešová K; Goldbergová-Pávková M; Lábrová R
    Kidney Blood Press Res; 2018; 43(6):1865-1877. PubMed ID: 30537724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of left ventricular function by tissue Doppler echocardiography in pediatric chronic kidney disease.
    Dogan CS; Akman S; Simsek A; Ozdem S; Comak E; Gokceoglu AU; Kardelen F; Koyun M
    Ren Fail; 2015 Aug; 37(7):1094-9. PubMed ID: 26123267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.
    Aceña Á; Pello AM; Carda R; Lorenzo Ó; Gonzalez-Casaus ML; Blanco-Colio LM; Martín-Ventura JL; Palfy J; Orejas M; Rábago R; Gonzalez-Parra E; Mahíllo-Fernández I; Farré J; Egido J; Tuñón J
    J Nutr Health Aging; 2016; 20(6):659-64. PubMed ID: 27273357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of arterial stiffness and electrocardiography-determined left ventricular hypertrophy with left ventricular diastolic dysfunction.
    Hsu PC; Tsai WC; Lin TH; Su HM; Voon WC; Lai WT; Sheu SH
    PLoS One; 2012; 7(11):e49100. PubMed ID: 23145083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum high-sensitivity cardiac troponin T is a significant biomarker of left-ventricular diastolic dysfunction in subjects with non-diabetic chronic kidney disease.
    Kitagawa M; Sugiyama H; Morinaga H; Inoue T; Takiue K; Kikumoto Y; Uchida HA; Kitamura S; Maeshima Y; Toh N; Nakamura K; Ito H; Makino H
    Nephron Extra; 2011 Jan; 1(1):166-77. PubMed ID: 22470390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma neutrophil gelatinase-associated lipocalin: a marker of acute pyelonephritis in children.
    Kim BK; Yim HE; Yoo KH
    Pediatr Nephrol; 2017 Mar; 32(3):477-484. PubMed ID: 27744618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
    Sakuragi S; Ichikawa K; Yamada K; Tanimoto M; Miki T; Otsuka H; Yamamoto K; Kawamoto K; Katayama Y; Tanakaya M; Ito H
    Int J Cardiol; 2015; 190():287-92. PubMed ID: 25932809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular mass and cardiac function in a population of children with chronic kidney disease.
    Mencarelli F; Fabi M; Corazzi V; Doyon A; Masetti R; Bonetti S; Castiglioni L; Pession A; Montini G
    Pediatr Nephrol; 2014 May; 29(5):893-900. PubMed ID: 24337408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal left ventricular longitudinal function assessed by echocardiographic and tissue Doppler imaging is a powerful predictor of diastolic dysfunction in hypertensive patients: the SPHERE study.
    Dini FL; Galderisi M; Nistri S; Buralli S; Ballo P; Mele D; Badano LP; Faggiano P; de Gregorio C; Rosa GM; Ciavarella M; De Marco E; Borruso E; Marti G; Mondillo S; Marino PN;
    Int J Cardiol; 2013 Oct; 168(4):3351-8. PubMed ID: 23647589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease.
    Katagiri M; Takahashi M; Doi K; Myojo M; Kiyosue A; Ando J; Hirata Y; Komuro I
    Heart Vessels; 2016 Oct; 31(10):1595-602. PubMed ID: 26614309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis.
    Lin HH; Lee JK; Yang CY; Lien YC; Huang JW; Wu CK
    Cardiovasc Diabetol; 2013 Aug; 12():127. PubMed ID: 24001037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
    Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proenkephalin, Neutrophil Gelatinase-Associated Lipocalin, and Estimated Glomerular Filtration Rates in Patients With Sepsis.
    Kim H; Hur M; Lee S; Marino R; Magrini L; Cardelli P; Struck J; Bergmann A; Hartmann O; Di Somma S;
    Ann Lab Med; 2017 Sep; 37(5):388-397. PubMed ID: 28643487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
    Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma Neutrophil Gelatinase-associated Lipoprotein in Living Kidney Donors.
    Yoon YE; Cho YI; Kim SY; Lee HH; Huh KH; Kim YS; Han WK
    Transplant Proc; 2016 Apr; 48(3):738-41. PubMed ID: 27234725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma neutrophil gelatinase-associated lipocalin as a predictive biomarker for the detection of acute kidney injury in adult poisoning.
    Ahn JY; Lee MJ; Seo JS; Choi D; Park JB
    Clin Toxicol (Phila); 2016; 54(2):127-33. PubMed ID: 26683351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.